GreenRoc Accelerates their World Class Project to Production as Early as 2028. Watch the full video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksYGEN.L Regulatory News (YGEN)

  • There is currently no data for YGEN

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Trading Statement

1 Apr 2009 08:10

RNS Number : 8916P
ViaLogy PLC
01 April 2009
 



VIALOGY PLC ("VIALOGY" OR "THE COMPANY") 

VIALOGY INCREASES STAKE IN SUCCESSFUL WELL

LONDONApril 1st, 2009 - ViaLogy PLC (LSE: VIY). ViaLogy announces that it has exercised an option with Atascosa Exploration LLC, of San Antonio, Texas ("Atascosa") to acquire an increased shareholding in the Galba Prospect oil well in South Central Texas ("Cindy Bartlett #2") found in March 2009 using its QuantumRD technology. ViaLogy now owns a 10% direct working interest in the Cindy Bartlett #2 well with revenue to ViaLogy expected to begin in Q2 this year. This means that ViaLogy will receive 10% of the Net Revenue Interest of the well over its lifespan. The amount of oil in the well has been calculated using industry standard core analysis practices.

 

ViaLogy has also agreed terms and dates with Atascosa for the near-term drilling of a second well on the Galba Prospect in south central Texas. Using ViaLogy's patented QuantumRD technology, the Company's scientists and Atascosa's geology and engineering team will immediately examine 3D seismic data and QuantumRD analysis to decide the optimum location position for the drilling rig. Spudding of the second well is expected to start within weeks.

ViaLogy's increased holding in Cindy Bartlett #2, and the drilling of the new well, to be called Cindy Bartlett #3, further cements the relationship with Atascosa following the success of QuantumRD which was announced on 23 March 2009 on the discovery of a series of three new oil formations at increasing depths on the Galba Prospect. The first well on the site, Cindy Bartlett #2, was drilled into the formation lying at 3,100 feet. Use of the QuantumRD seismic interpretation technology verifies the presence of hydrocarbons, permits characterization of the reservoir and porosity, and siting of the drill location. The technology is based on protected active signal processing software capable of exploiting the "noise" inherent in most seismic data. 

 

"For the immediate future we are focussing our activities on Texas," said ViaLogy's Chief Executive, Robert W. Dean. "We have a new technology that is proving its ability to improve the ratio of producing successful wells instead of dry holes, which for on-shore drilling in the continental USA currently occur in six cases out of ten. But the real secret is to combine our value-added ability to more effectively interpret the seismic data with the experience of geologists and oil men who know the areain which we work." 

"In this regard, over the past six months we've developed an excellent working relationship with Atascosa Exploration, and both companies have agreed to work closely together on future projects. So we welcomed the opportunity when Atascosa offered us a larger participation in the successful well we'd developed together."

 

Ends

 

For further information please contact:

ViaLogy

Robert W Dean, President & CEO - US +1 626-296-6337 (mobile: +1 703-589-3807) Terry Bond, Chairman - UK & Europe +44 (0) 1235-834734 (mobile: 07860 842756)

Atascosa Exploration LLC   John D. Mullins, CEO (+1 210-402-3656) 

Nominated Advisor to ViaLogy PLC (Seymour Pierce)   Mark Percy +44 (0) 20-7107-8000

Broker to ViaLogy PLC (St. Helen's Capital)

Ruari McGirr / Sebastian Wykeham +44 (0) 207 628 5582 

 

About ViaLogy: 

ViaLogy is a leading innovator of network-centric, real-time signal processing platforms for sensor applications. ViaLogy is currently deploying and designing computational systems, powered by its patented technologies, for applications in life sciences, public safety and security, surveillance, defense and geoseismology. ViaLogy focuses on market driven problems where automation, timeliness, quality and reliability of information processing are essential. ViaLogy's core competency incorporates rapidly and accurately detecting weak signals buried in high noise background and clutter. This technology can be employed to solve problems involving sensor integration and information overload challenges involving video, telephony and control sensors, as well as for enhancement of numerous signal processing applications. For more information, visit our website at www.ViaLogy.com

Except for statements of historical fact, the information presented herein constitutes forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Such forward-looking statements involve known and unknown risks, uncertainties and other factors which may cause the actual results, performance or achievements of the company to be materially different from any future results, performance or achievements expressed or implied.

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TSTUUUMUCUPBUMG
Date   Source Headline
5th Nov 20207:00 amRNSDirectorate Change
3rd Nov 20207:00 amRNSPartnership with Take2 Health Limited
26th Oct 20207:00 amRNSHalf-year Trading update
23rd Oct 20207:00 amRNSCQC accreditation
21st Oct 20207:00 amRNSYourgene Genomic Services collaboration with Cytox
12th Oct 20207:00 amRNSElucigene DPYD tests to be used routinely in Wales
8th Oct 20207:00 amRNSStrategic reproductive health partnership in Japan
7th Oct 20207:00 amRNSIONA®Nx awarded contract with St George’s Hospital
5th Oct 20207:00 amRNSShare Incentive Plan
1st Oct 20204:59 pmRNSCorrection: Holding(s) in Company
1st Oct 20203:29 pmRNSHolding(s) in Company
28th Sep 20207:00 amRNSLaunch of Yourgene Genomic Services
25th Sep 20205:28 pmRNSIssue of Share Options
24th Sep 202010:00 amRNSDPD reimbursement in Germany
24th Sep 20207:00 amRNSDirector/PDMR Shareholding
23rd Sep 20205:20 pmRNSExercise of Options
23rd Sep 202012:25 pmRNSDirector/PDMR Shareholding
22nd Sep 20205:14 pmRNSResult of AGM
22nd Sep 20207:00 amRNSAGM Statement
21st Sep 20207:00 amRNSUS distribution agreement for DPYD &other products
9th Sep 20207:00 amRNSAGM update and investor presentation
3rd Sep 20207:00 amRNSIONA® Nx Launch
28th Aug 20207:00 amRNSNotice of AGM & Annual Report 2020
13th Aug 20207:00 amRNSTGA approves IONA® Nx for sale in Australia
11th Aug 20207:00 amRNSAdmission of Company Considerations Shares and TVR
7th Aug 20203:42 pmRNSHolding(s) in Company
7th Aug 20203:25 pmRNSHolding(s) in Company
7th Aug 20209:48 amRNSHolding(s) in Company
5th Aug 20201:15 pmRNSResult of Placing
5th Aug 20207:00 amRNS£16.15m Placing & Close of Accelerated Bookbuild
4th Aug 20205:13 pmRNSProposed Acquisition and Placing
3rd Aug 20207:00 amRNSCE-IVD Mark for Clarigene™ SARS-CoV-2 test
29th Jul 202012:05 pmRNSAppointment of Joint Broker
28th Jul 20207:00 amRNSFinal Results
13th Jul 20201:13 pmRNSNotice of Results
30th Jun 20207:00 amRNSCOVID-19 assay launched
19th Jun 20204:44 pmRNSIssue of Share Options
16th Jun 20207:00 amRNSCollaboration in COVID-19 testing
15th Jun 20207:00 amRNSCE-IVD mark received for Illumina-based IONA® test
26th May 202012:00 pmRNSHolding(s) in Company
26th May 20207:00 amRNSCOVID-19 testing service launch; business update
20th May 20207:00 amRNSExercise of Warrants and Options
20th Apr 20207:00 amRNSYear-end Trading update: Revenues increase 86%
16th Apr 20204:41 pmRNSSecond Price Monitoring Extn
16th Apr 20204:35 pmRNSPrice Monitoring Extension
14th Apr 20204:41 pmRNSSecond Price Monitoring Extn
14th Apr 20204:36 pmRNSPrice Monitoring Extension
14th Apr 20202:06 pmRNSSecond Price Monitoring Extn
14th Apr 20202:01 pmRNSPrice Monitoring Extension
7th Apr 20207:00 amRNSPresentation on ‘Adapting during crisis’

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.